Ramtin Agah
About
Ramtin Agah is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Ramtin Agah has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ramtin Agah's work include Pancreatic and Hepatic Oncology Research (8 papers), Cancer Genomics and Diagnostics (5 papers) and Ocular and Laser Science Research (4 papers). Ramtin Agah is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Cancer Genomics and Diagnostics (5 papers) and Ocular and Laser Science Research (4 papers). Ramtin Agah collaborates with scholars based in United States, Canada and Switzerland. Ramtin Agah's co-authors include Peter Frenkel, Brent A. French, Michel Schneider, Paul A. Overbeek, Massoud Motamedi, David A. Dichek, Ashley J. Welch, John A. Pearce, Michael Schneider and L D Truong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
In The Last Decade
Ramtin Agah
29 papers receiving 1.2k citations
Peers
Ramtin Agah
David F. Meoli United States
Salman Rahman United States
Outi Närvänen Finland
Peter Andersen United States
Cathy Paddock United States
Michael Maysky United States
Silvia Moimas Italy
Annica Pontén Sweden
Jennifer Macko United States
Laurence F. Morton United Kingdom
Citations per year, relative to Ramtin Agah Ramtin Agah (= 1×)
peers
David F. Meoli
Countries citing papers authored by Ramtin Agah
Since
Specialization
Citations
This map shows the geographic impact of Ramtin Agah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramtin Agah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramtin Agah more than expected).
Fields of papers citing papers by Ramtin Agah
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ramtin Agah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramtin Agah. The network helps show where Ramtin Agah may publish in the future.
Co-authorship network of co-authors of Ramtin Agah
This figure shows the co-authorship network connecting the top 25 collaborators of Ramtin Agah. A scholar is included among the top collaborators of Ramtin Agah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramtin Agah. Ramtin Agah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hatoum, Hassan, Alexander S. Rosemurgy, J. Augusto Bastidas, et al.. (2024). Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. The Oncologist. 29(8). 690–698.
2.
Farsad, Khashayar, Paula M. Novelli, Ripal Gandhi, et al.. (2024). Double-Balloon Catheter–Mediated Transarterial Chemotherapy Delivery in a Swine Model: A Mechanism Recruiting the Vasa Vasorum for Localized Therapies. Journal of Vascular and Interventional Radiology. 35(7). 1043–1048.e3.
3.
Pishvaian, Michael J., Charles D. Lopez, Emmanuel E. Zervos, et al.. (2023). LBA-1 The Phase III Study: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC). Annals of Oncology. 34. S178–S178.
4.
Pishvaian, Michael J., Amer H. Zureikat, Charles D. Lopez, et al.. (2023). Abstract CT084: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following Induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC) - phase III trial interim analysis. Cancer Research. 83(8_Supplement). CT084–CT084.
5.
Goodman, Karyn A., Michael J. Pishvaian, Charles D. Lopez, et al.. (2023). Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial.. Journal of Clinical Oncology. 41(4_suppl). 713–713.
6.
Pishvaian, Michael J., Amer H. Zureikat, Charles D. Lopez, et al.. (2023). Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC): A randomized phase 3 multicenter study.. Journal of Clinical Oncology. 41(4_suppl). TPS773–TPS773.
7.
Rosemurgy, Alexander S., et al.. (2017). Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. 3(1). 58–65.
8.
Rosemurgy, Alexander S., et al.. (2017). Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. SHILAP Revista de lepidopterología. 3(1). 58–65.
9.
Tandar, Anwar, et al.. (2006). Diffuse aneurysmal disease. Clinical Cardiology. 29(9). 423–423.
10.
Chan, Albert W., Jay S. Yadav, Deepak L. Bhatt, et al.. (2005). Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. The American Journal of Cardiology. 95(6). 791–795.
11.
Lee, Sun‐Young, Ramtin Agah, Ming Xiao, et al.. (2005). In vivo expression of a conditional TGF-β1 transgene: no evidence for TGF-β1 transgene expression in SM22α-tTA transgenic mice. Journal of Molecular and Cellular Cardiology. 40(1). 148–156.
12.
Agah, Ramtin, Stephen G. Ellis, Mark Henderson, et al.. (2005). Creation of a large-scale genetic data bank for cardiovascular association studies. American Heart Journal. 150(3). 500–506.
13.
Agah, Ramtin & Eric J. Topol. (2002). Genetic testing for coronary heart disease: the approaching frontier. Expert Review of Molecular Diagnostics. 2(5). 448–460.
14.
Camargo, Fernando D., Aloke V. Finn, Aaron E. Cozen, et al.. (2000). Germline Incorporation of a Replication-Defective Adenoviral Vector in Mice Does Not Alter Immune Responses to Adenoviral Vectors. Molecular Therapy. 2(5). 496–504.
15.
Agah, Ramtin, Lorrie A. Kirshenbaum, Maha Abdellatif, et al.. (1997). Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.. Journal of Clinical Investigation. 100(11). 2722–2728.
16.
Agah, Ramtin, et al.. (1997). Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.. Journal of Clinical Investigation. 100(1). 169–179.
17.
Agah, Ramtin, Valeria Bandi, & K. K. Guntupalli. (1997). Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Medicine. 23(7). 793–796.
18.
Agah, Ramtin, et al.. (1996). Fatal cerebral venous thrombosis as the initial manifestation of the antiphospholipid syndrome. Clinical Neurology and Neurosurgery. 98(2). 189–191.
19.
Agah, Ramtin, John A. Pearce, Ashley J. Welch, & Massoud Motamedi. (1994). Rate process model for arterial tissue thermal damage: Implications on vessel photocoagulation. Lasers in Surgery and Medicine. 15(2). 176–184.
20.
Pearce, John A., Ashley J. Welch, Massoud Motamedi, & Ramtin Agah. (1986). THERMOGRAPHIC MEASUREMENT OF TISSUE TEMPERATURE DURING LASER ANGIOPLASTY.. 61. 49–54.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by David F. Meoli Breakdown of academic impact, for papers by Salman Rahman Breakdown of academic impact, for papers by Outi Närvänen Breakdown of academic impact, for papers by Peter Andersen Breakdown of academic impact, for papers by Cathy Paddock Breakdown of academic impact, for papers by Michael Maysky Breakdown of academic impact, for papers by Silvia Moimas Breakdown of academic impact, for papers by Annica Pontén Breakdown of academic impact, for papers by Jennifer Macko Breakdown of academic impact, for papers by Laurence F. Morton